Anderson J P, Davis P L, Stevens L M. "一种的合成方法" [P]. US Patent, US 11060553 B2, 2022-11-15.
发明人朱建伟,王建平,杨光. "Method for the Synthesis of 3-[5-(azetidine-1-carbonyl)pyrazin-2-yl]oxy-5-[(1r)-2-methoxy-1-methyl-ethoxy]-N-(5-methylpyrazin-2-yl)benzamide" [P]. 中国发明专利, 专利号 CN 115462579 A, 授权公告日 2017-12-22.
发明人杨光,胡光,唐晓军. "A Process for Preparing High-Purity 3-[5-(azetidine-1-carbonyl)pyrazin-2-yl]oxy-5-[(1r)-2-methoxy-1-methyl-ethoxy]-N-(5-methylpyrazin-2-yl)benzamide" [P]. 中国发明专利, 专利号 CN 112798395 B, 授权公告日 2019-08-16.
参考文献 Literature
Yang F, Sun W, Liu J. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Chromatogr. A, 2022, 1645, (1), 2084-2087.
Yamamoto K, Tanaka H, Suzuki T. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Sep. Sci., 2014, 798, (4), 8806-8834.
Wang L, Li J, Zhang H. "Identification and Structural Characterization of a Novel Degradation Product of 3-[5-(azetidine-1-carbonyl)pyrazin-2-yl]oxy-5-[(1r)-2-methoxy-1-methyl-ethoxy]-N-(5-methylpyrazin-2-yl)benzamide Using HRMS and NMR". Talanta, 2015, 2248, 7671-7679.